BROILER PMX NO. 1620
-
amprolium and
ethopabate powder
Huvepharma, Inc.
----------
BROILER PMX NO. 1620 - amprolium and
ethopabate powder
Huvepharma, Inc.
----------
AMPROL PLUSNADA 13-461
Approved by the FDA
AMPROL PLUS
Product 956750
(amprolium with ethopabate)
Type A Medicated Article
AMPROL PLUS
(amprolium, ethopabate) is intended for use as an aid in the
prevention of
coccidiosis (1) in broiler chickens and (2) in replacement chickens
where
immunity to coccidiosis is not desired.
ACTIVE DRUG
INGREDIENTS: Amprolium ............................... 25%
Ethopabate .......................
0.8%
INGREDIENTS: Corn Gluten Feed and Soybean
Oil
SEE DIRECTIONS ON BACK
PANEL
Manufactured by:
HUVEPHARMA, INC.
St. Louis, MO
63116
Distributed by:
Huvepharma, Inc.
Peachtree City, GA 30269
® AMPROL PLUS and ® AMPROL are registered trademarks of Huvepharma,
Inc.
Net Wt.: 50 LB (22.68 kg)
WARNING
Keep this and all drugs
out of the reach of children. NOT FOR HUMAN USE
The Material
Safety Data Sheet (MSDS) contains more detailed occupational safety information.
To report adverse effects,
obtain an MSDS or for assistance, contact
Huvepharma at 1-877-4AMPROL
MIXING DIRECTIONS
AMPROL PLUS
(amprolium, ethopabate) should be thoroughly and evenly mixed in the feed.
AMPROL PLUS may be used
to manufacture a Type C medicated feed in the
concentration range of 0.0125% - 0.025% amprolium and 0.0004% ethopabate.
One pound of AMPROL PLUS should be mixed with one ton of non-medicated feed
to produce a Type C medicated
feed containing 0.0125% amprolium / 0.0004%
ethopabate. One pound of AMPROL PLUS and one pound of AMPROL
(amprolium) 25%
mixed with one ton of non-medicated feed will produce a feed containing 0.025%
amprolium and
0.0004% ethopabate.
To aid in the even distribution of
AMPROL PLUS in the finished feed, prepare a mixture of AMPROL PLUS in a portion
of complete
feed ingredient before mixing into the finished ration. Blend the
mixture with the remainder of the finished feed and mix thoroughly.
SUGGESTED DIRECTIONS FOR FEED TAGS
Use Directions
CHICKENS: For most field conditions as
they exist under modern management practices use 0.0125% amprolium
0.0004%
ethopabate Type C medicated feed. Where severe coccidiosis conditions
exist, use 0.025% amprolium-0.0004% ethopabate Type C
medicated feed.
Increasing levels of Amprolium may not prevent coccidiosis caused by strains of
Eimeria commonly found to be
resistant to
Amprolium.
Use amprolium-ethopabate Type C medicated feed as the only
ration from the time birds are placed on litter until past the time
when
coccidiosis is ordinarily a hazard.
CAUTION
Not for laying hens.
Withdraw 5 days before slaughter for broiler
chickens.
Use as the sole source of amprolium.
Do not use
amprolium-ethopabate Type C medicated feed as a treatment for outbreaks of
coccidiosis.
Do not change the litter while giving this feed unless
absolutely necessary.
If losses exceed 0.5% in a 2-day period, obtain an
accurate diagnosis, and follow the instructions of your veterinarian or
poultry
pathologist. Losses may result from intercurrent disease or other
conditions affecting drug intake which can contribute to the
virulence of
coccidiosis under field conditions.
Do not use in feeds containing
bentonite.
Restricted Drug (California) - Use Only as
Directed.
AMPROL PLUS
(amprolium with
ethopabate)
Type A Medicated Article
1075-1557-04
Dated 09-2007
BROILER PMX NO. 1620
amprolium powder |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NADA | NADA013461 | 06/29/2009 |
Labeler - Huvepharma, Inc. (619153559) |
Registrant - Huvepharma AD (552691651) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Huvepharma, Inc. | 883128204 | manufacture, analysis, pack, label |
Revised: 07/2012 Huvepharma, Inc.